Cargando…
Regulatory Cues in Pulmonary Fibrosis—With Emphasis on the AIM2 Inflammasome
Pulmonary fibrosis (PF) is a chronic lung disorder characterized by the presence of scarred and thickened lung tissues. Although the Food and Drug Administration approved two antifibrotic drugs, pirfenidone, and nintedanib, that are currently utilized for treating idiopathic PF (IPF), the clinical t...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10341703/ https://www.ncbi.nlm.nih.gov/pubmed/37446052 http://dx.doi.org/10.3390/ijms241310876 |